Premium
P3‐001: A RANDOMIZED, PLACEBO‐CONTROLLED TRIAL TO INVESTIGATE SAFETY OF BUPRENORPHINE TRANSDERMAL SYSTEM FOR PAIN MANAGEMENT IN PEOPLE WITH DEMENTIA
Author(s) -
Erdal Ane,
Flo Elisabeth,
Aarsland Dag,
Ballard Clive,
Husebø Bettina Sandgathe
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1356
Subject(s) - medicine , discontinuation , buprenorphine , adverse effect , placebo , randomized controlled trial , dementia , population , anesthesia , opioid , alternative medicine , receptor , disease , environmental health , pathology
P3-001 A RANDOMIZED, PLACEBOCONTROLLED TRIAL TO INVESTIGATE SAFETY OF BUPRENORPHINE TRANSDERMAL SYSTEM FOR PAIN MANAGEMENT IN PEOPLE WITH DEMENTIA Ane Erdal, Elisabeth Flo, Dag Aarsland, Clive Ballard, Bettina Sandgathe Husebø, University of Bergen, Bergen, Norway; Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom; University of Exeter Medical School, Exeter, United Kingdom. Contact e-mail: c.ballard@exeter.ac.uk